新天药业
(002873)
| 流通市值：17.67亿 | | | 总市值：17.99亿 |
| 流通股本：2.40亿 | | | 总股本：2.44亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 503,491,479.47 | 331,825,486.07 | 178,610,160.01 | 749,720,071.32 |
| 营业总成本 | 493,174,209.07 | 325,225,898.53 | 174,084,468.5 | 744,175,673.38 |
| 其他经营收益 | | | | |
| 营业利润 | 18,058,478.87 | 8,281,992.48 | 5,229,045.38 | 10,071,031.97 |
| 利润总额 | 17,849,118.84 | 8,208,474.57 | 5,245,449.07 | 9,769,456.61 |
| 净利润 | 16,705,690.84 | 4,861,436.22 | 3,495,173.12 | 9,111,475.81 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | 66,535,046.25 |
| 综合收益总额 | 16,705,690.84 | 4,861,436.22 | 3,495,173.12 | 75,646,522.06 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 550,659,931.19 | 565,224,906.67 | 614,129,490.15 | 651,035,036.56 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,486,422,875.77 | 1,488,689,545.09 | 1,477,650,069.41 | 1,470,039,271.29 |
| 资产总计 | 2,037,082,806.96 | 2,053,914,451.76 | 2,091,779,559.56 | 2,121,074,307.85 |
| 流动负债: | | | | |
| 流动负债合计 | 443,119,439.17 | 442,278,004.16 | 457,226,805.08 | 380,195,259.93 |
| 非流动负债: | | | | |
| 非流动负债合计 | 303,569,690.17 | 333,087,024.6 | 374,813,078.16 | 484,634,544.72 |
| 负债合计 | 746,689,129.34 | 775,365,028.76 | 832,039,883.24 | 864,829,804.65 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,290,393,677.62 | 1,278,549,423 | 1,259,739,676.32 | 1,256,244,503.2 |
| 股东权益合计 | 1,290,393,677.62 | 1,278,549,423 | 1,259,739,676.32 | 1,256,244,503.2 |
| 负债和股东权益合计 | 2,037,082,806.96 | 2,053,914,451.76 | 2,091,779,559.56 | 2,121,074,307.85 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 629,344,772.91 | 416,616,271.59 | 200,090,397.92 | 852,090,617.14 |
| 经营活动现金流出小计 | 453,223,441.51 | 306,577,575.66 | 156,471,670.78 | 768,355,874.81 |
| 经营活动产生的现金流量净额 | 176,121,331.4 | 110,038,695.93 | 43,618,727.14 | 83,734,742.33 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 17,216,643.18 | 15,021,500 | 15,000,000 | 17,149,190.1 |
| 投资活动现金流出小计 | 63,924,670.84 | 57,985,064.96 | 34,935,053.48 | 109,581,316.55 |
| 投资活动产生的现金流量净额 | -46,708,027.66 | -42,963,564.96 | -19,935,053.48 | -92,432,126.45 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 310,326,279.35 | 180,233,258.48 | 23,612,500 | 532,750,971.36 |
| 筹资活动现金流出小计 | 418,761,771.59 | 238,614,414.24 | 53,890,547.66 | 468,498,440.32 |
| 筹资活动产生的现金流量净额 | -108,435,492.24 | -58,381,155.76 | -30,278,047.66 | 64,252,531.04 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 20,977,811.5 | 8,693,975.21 | -6,594,374 | 55,555,146.92 |
| 期末现金及现金等价物余额 | 194,697,386.3 | 182,413,550.01 | 167,125,200.8 | 173,719,574.8 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 8,693,975.21 | - | 55,555,146.92 |